Concepedia

Barry J. Gertz

BJ

56

Publications

6.2K

Citations

37

H-Index

1979

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

KU Leuven

United States Military Academy

University of California, San Francisco

Baylor College of Medicine

Barry J. Gertz is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacology, and pharmacotherapy.

Top concepts

Publications per year

1979–2023

56

Publications

56

Effects of Specific Inhibition of Cyclooxygenase-2 on Sodium Balance, Hemodynamics, and Vasoactive Eicosanoids

Francesca Catella-Lawson, Brendan McAdam, Briggs Morrison et al. · Journal of Pharmacology and Experimental Therapeutics · 1999 · 595 citations

Induction of Adipocyte Complement-Related Protein of 30 Kilodaltons by PPARγ Agonists: A Potential Mechanism of Insulin Sensitization

Terry P. Combs, John A. Wagner, Joel P. Berger et al. · Endocrinology · 2002 · 566 citations

Regulation of muscle growth by multiple ligands signaling through activin type II receptors

Se‐Jin Lee, Lori A. Reed, Monique V. Davies et al. · Proceedings of the National Academy of Sciences · 2005 · 493 citations · Full text

Reduction of Cisplatin-Induced Emesis by a Selective Neurokinin-1–Receptor Antagonist

Rudolph M. Navari, Rick R. Reinhardt, Richard J. Gralla et al. · New England Journal of Medicine · 1999 · 370 citations · Full text

Comparative Inhibitory Activity of Rofecoxib, Meloxicam, Diclofenac, Ibuprofen, and Naproxen on COX‐2 versus COX‐1 in Healthy Volunteers

Anne Van Hecken, Jules I. Schwartz, Marleen Depré et al. · The Journal of Clinical Pharmacology · 2000 · 355 citations

Rows per page

1–5 of 56